Melatonin in perimenopausal and postmenopausal women: Associations with mood, sleep, climacteric symptoms, and quality of life

Menopause

Volumn 21, Issue 5, 2014, Pages 493-500

  Toffol, Elena ^a,b   Kalleinen, Nea ^c,d   Haukka, Jari ^a,b   Vakkuri, Olli ^e   Partonen, Timo ^a   Polo Kantola, Päivi ^c,d  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF OULU   (Finland)

Author keywords

Melatonin; Mood; Perimenopause; Postmenopause; Quality of life; Sleep

Indexed keywords

ESTRADIOL; FOLLITROPIN; MELATONIN;

ADULT; AGED; ANXIETY; ARTICLE; BASIC NORDIC SLEEP QUESTIONNAIRE; BECK DEPRESSION INVENTORY; BLOOD SAMPLING; BODY MASS; CLIMACTERIUM; CLINICAL ARTICLE; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; INSOMNIA; MENOPAUSAL SYNDROME; MOOD; POSTMENOPAUSE; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SLEEP; SLEEP QUALITY; SOMNOLENCE; STATE TRAIT ANXIETY INVENTORY; VASOMOTOR DISORDER; AFFECT; BLOOD; COMPARATIVE STUDY; MIDDLE AGED; PHYSIOLOGY;

ADULT; AFFECT; AGED; BODY MASS INDEX; CLIMACTERIC; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; MELATONIN; MIDDLE AGED; POSTMENOPAUSE; QUALITY OF LIFE; SLEEP;

EID: 84899936257     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0b013e3182a6c8f3     Document Type: Article

References (64)

1. Bubenik GA. Gastrointestinal melatonin. Localization, function andclinical relevance. Dig Dis Sci 2002;47:2336-2348.
2. Arendt J. Melatonin: characteristics, concerns, and prospects. J BiolRhythms 2005;20:291-303.
3. Okatani Y, Morioka N, Hayashi K. Changes in nocturnal pineal melatoninsynthesis during the perimenopausal period: relation to estrogenlevels in female rats. J Pineal Res 1999;27:65-72.
4. San Martin M, Touitou Y. Progesterone inhibits, on a circadian basis, therelease of melatonin by rat pineal perifusion. Steroids 2000;65:206-209.
5. Hernández-Díaz FJ, Sánchez JJ, Abreu P, et al. Estrogen modulates 1/AadrenoceptorYinducedsignaling and melatonin production in female ratpinealocytes. Neuroendocrinology 2001;73:111-122.
6. Caufriez A, Leproult R, L'Hermite-Baleriaux M, Kerkhofs M, CopinschiG. Progesterone prevents sleep disturbances and modulates GH, TSH,and melatonin secretion in postmenopausal women. J Clin EndocrinolMetab 2011;96:E614-E623.
7. Okatani Y, Sagara Y. Amplification of nocturnal melatonin secretion inwomen with functional secondary amenorrhoea: relation to endogenousoestrogen concentration. Clin Endocrinol 1994;41:763-770.
8. Ishizuka B, Fusama S, Hirai K, et al. Melatonin secretion from organculturedpineal glands of rats: modulation by gonadectomy andgonadotropin-releasing hormone agonist administration. Eur J Endocrinol2000;142:387-392.
9. Kostoglou-Athanassiou I, Athanassiou P, Treacher DF, Wheeler MJ,Forsling ML. Neurohypophysial hormone and melatonin secretion overthe natural and suppressed menstrual cycle in premenopausal women.Clin Endocrinol 1998;49:209-216.
10. Woo MMM, Tai C-J, Kang SK, Nathwani PS, Pang SF, Leung PCK.Direct action of melatonin in human granulosa-luteal cells. J ClinEndocrinol Metab 2001;86:4789-4797.
11. Cos S, González A, Mart?́nez-Campa C, Mediavilla MD, Alonso-González C, Sánchez-Barceló EJ. Melatonin as a selective estrogen enzymemodulator. Curr Cancer Drug Targets 2008;8:691-702.
12. Voordouw BC, Euser R, Verdonk RE, et al. Melatonin and melatoninprogestincombinations alter pituitary-ovarian function in women and caninhibit ovulation. J Clin Endocrinol Metab 1992;74:108-117.
13. Reiter RJ. Melatonin and human reproduction. Ann Med 1998;30:103-108.
14. Brzezinski A, Lynch HJ, Siebel MM, Deng MH, Nader TM, WurtmanRJ. The circadian rhythm of plasma melatonin during the normal menstrualcycle and in amenorrheic women. J Clin Endocrinol Metab1988;66:891-895.
15. Luboshitzky R, Lavi S, Thuma I, Lavie P. Increased nocturnal melatoninsecretion in male patients with hypogonadotropic hypogonadism anddelayed puberty. J Clin Endocrinol Metab 1995;80:2144-2148.
16. Iguchi H, Kato K, Ibayashi H. Age-dependent reduction in serum melatoninconcentrations in healthy human subjects. J Clin Endocrinol Metab1982;55:27-29.
17. Kennaway DJ, Lushington K, Dawson D, Lack L, Van den Heuvel C,Rogers N. Urinary 6-sulfatoxymelatonin excretion and aging: new resultsand a critical review of the literature. J Pineal Res 1999;27:210-220.
18. Fernandez B, Malde JL, Montero A, Acuña D. Relationship betweenadenohypophyseal and steroid hormones and variations in serum andurinary melatonin levels during the ovarian cycle, perimenopause andmenopause in healthy women. J Steroid Biochem 1990;35:257-262.
19. Vakkuri O, Kivelä A, Leppäluoto J, Valtonen M, Kauppila A. Decreasein melatonin precedes follicle-stimulating hormone increase during perimenopause.Eur J Endocrinol 1996;135:188-192.
20. Okatani Y, Morioka N, Wakatsuki A. Changes in nocturnal melatoninsecretion in perimenopausal women: correlation with endogenous estrogenconcentrations. J Pineal Res 2000;28:111-118.
21. Kotlarczyk MP, Lassila HC, O'Neil CK, et al. Melatonin OsteoporosisPrevention Study (MOPS): a randomized, double-blind, placebocontrolledstudy examining the effects of melatonin on bone health andquality of life in perimenopausal women. J Pineal Res 2012;52:414-426.
22. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Sex anddepression in the National Comorbidity Survey, 1: lifetime prevalence,chronicity and recurrence. J Affect Disord 1993;29:85-96.
23. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormonesand menopausal status with depressed mood in women with nohistory of depression. Arch Gen Psychiatry 2006;63:375-382.
24. Deecher D, Andree TH, Sloan D, Schechter LE. From menarche tomenopause: exploring the underlying biology of depression in womenexperiencing hormonal changes. Psychoneuroendocrinology 2008;33:3-17.
25. Nowakowski S, Meliska CJ, Martinez LF, Parry BL. Sleep and menopause.Curr Neurol Neurosci Rep 2009;9:165-172.
26. Hachul H, Andersen ML, Bittencourt LR, Santos-Silva R, Conway SG,Tufik S. Does the reproductive cycle influence sleep patterns in womenwith sleep complaints? Climacteric 2010;13:594-603.
27. Polo-Kantola P. Sleep problems in midlife and beyond. Maturitas2011;68:224-232.
28. Eichling PS, Sahni J. Menopause related sleep disorders. J Clin SleepMed 2005;1:291-300.
29. Polo-Kantola P. Sleep and menopause. Womens Health 2007;3:99-106.
30. Beck-Friis J, von Rosen D, Kjellman BF, Ljunggren JG, Wetterberg L.Melatonin in relation to body measures, sex, age, season and the use ofdrugs in patients with major affective disorders and healthy subjects. Psychoneuroendocrinology 1984;9:261-277.
31. Claustrat B, Chazot G, Brun J, Jordan D, Sassolas G. A chronobiologicalstudy of melatonin and cortisol secretion in depressed subjects: plasmamelatonin, a biochemical marker in major depression. Biol Psychiatry1984;19:1215-1228.
32. Beck-Friis J, Kjellman BF, Aperia B, et al. Serum melatonin in relationto clinical variables in patients with major depressive disorder and ahypothesis of a low melatonin syndrome. Acta Psychiatr Scand 1985;71:319-330.
33. Brown R, Kocsis JH, Caroff S, et al. Differences in nocturnal melatoninsecretion between melancholic depressed patients and control subjects.Am J Psychiatry 1985;142:811-816.
34. Crasson M, Kjiri S, Colin A, et al. Serum melatonin and urinary 6-sulfatoxymelatonin in major depression. Psychoneuroendocrinology2004;29:1-12.
35. Parry BL, Meliska CJ, Sorenson DL, et al. Increased melatonin and delayedoffset in menopausal depression: role of years post-menopause,follicle- stimulating hormone, sleep end time, and body mass index. J ClinEndocrinol Metab 2008;93:54-60.
36. Naranjo-Rodriguez EB, Osornio AO, Hernandez-Avitia E, Mendoza-Fernández V, Escobar A. Anxiolytic-like actions of melatonin, 5-metoxytryptophol, 5-hydroxytryptophol and benzodiazepines on aconflict procedure. Prog Neuropsychopharmacol Biol Psychiatry 2000;24:117-129.
37. Papp M, Litwa E, Gruca P, Mocaer E. Anxiolytic-like activity ofagomelatine and melatonin in three animal models of anxiety. BehavPharmacol 2006;17:9-18.
38. Stein DJ, Ahokas AA, De Bodinat C. Efficacy of agomelatine in generalizedanxiety disorder. A randomized, double-blind, placebo- controlledstudy. J Clin Psychopharmacol 2008;28:561-566.
39. Cardinali DP, Srinivasan V, Brzezinski A, Brown GM. Melatonin and itsanalogs in insomnia and depression. J Pineal Res 2012;52:365-375.
40. Kalleinen N, Polo-Kantola P, Himanen S-L, et al. Sleep and themenopauseVdo postmenopausal women experience worse sleep thanpremenopausal women? Menopause Int 2008;14:97-104.
41. Vakkuri O, Leppäluoto J, Vuolteenaho O. Development and validation ofa melatonin radioimmunoassay using radioiodinated melatonin as tracer.Acta Endocrinol 1984;106:152-157.
42. Lewy AJ. The dim light melatonin onset, melatonin assays and biologicalrhythms research in humans. Biol Signals Recept 1999;8:79-83.
43. Lewy AJ, Culter NL, Sack RL. The endogenous melatonin profile as amarker for circadian phase position. J Biol Rhythms 1999;14:227-236.
44. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory formeasuring depression. Arch Gen Psychiatry 1961;4:561-571.
45. Spielberger CD, Gorssuch RL, Lushene PR, Vagg PR, Jacobs GA.Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: ConsultingPsychologists Press Inc, 1983.
46. Partinen M, Gislason T. Basic Nordic Sleep Questionnaire (BNSQ): aquantitated measure of subjective sleep complaints. J Sleep Res 1995;4:150-155.
47. Ohinmaa A, Sintonen H, Badia X, Herdman M, Segura A. Quality of lifeof Finnish population as measured by EuroQoL. In: EuroQoL, PlenaryMeeting, Barcelona, Spain, October 3-5, 1995: Discussion Papers.Barcelona, Spain: Catalan Institute of Public Health, 1996:161-172.
48. EQ-5D User Guide. Available at: www.euroqol.org/about-eq-5d/publications/ user-guide.html. Accessed August 28, 2013.
49. Team R Development Core. R: a language and environment for statisticalcomputing. Vienna, Austria. Available at: http://www.R-project.org/. Accessed August 28, 2013.
50. Benloucif S, Burgess HJ, Klerman EB, et al. Measuring melatonin inhumans. J Clin Sleep Med 2008;4:66-69.
51. Walters JF, Hampton SM, Ferns GA, Skene DJ. Effect of menopause onmelatonin and alertness rhythms investigated in constant routine conditions.Chronobiol Int 2005;22:859-872.
52. Gibson CJ, Thurston RC, El Khoudary SR, Sutton-Tyrrell K, MatthewsKA. Body mass index following natural menopause and hysterectomywith and without bilateral oophorectomy. Int J Obes 2013;37:809-813.
53. Baxi D, Singh PK, Vachhrajani K, Ramachandran AV. Melatonin supplementationtherapy as a potent alternative to ERT in ovariectomizedrats. Climacteric 2012;15:382-392.
54. Bellipanni G, Di Marzo F, Blasi F, Di Marzo A. Effects of melatonin inperimenopausal and menopausal women. Our personal experience. AnnN Y Acad Sci 2005;1057:393-402.
55. Secreto G, Chiechi LM, Amadori A, et al. Soy isoflavones and melatoninfor the relief of climacteric symptoms: a multicenter, double-blind, randomizedstudy. Maturitas 2004;47:11-20.
56. Kripke DF, Kline LE, Shadan F, Dawson A, Poceta JS, Elliott JA.Melatonin effects on luteinizing hormone in postmenopausal women: apilot clinical trial NCT00288262. BMC Womens Health 2006;6:8.
57. Kuh DL, Wadsworth M, Hardy R. Women's health in midlife: the influenceof the menopause, social factors and health in earlier life. Br JObstet Gynaecol 1997;104:923-933.
58. Owens JF, Matthews KA. Sleep disturbance in healthy middle-agedwomen. Maturitas 1998;30:41-50.
59. Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K,Meyer PM. Sleep difficulty in women at midlife. Menopause 2003;10:19-28.
60. Berecki-Gisolf J, Begum N, Dobson AJ. Symptoms reported by womenin midlife: menopausal transition or aging? Menopause 2009;16:1021-1029.
61. Hachul H, Bittencourt LRA, Soares JM Jr, Tufik S, Baracat EC. Sleep inpost-menopausal women: differences between early and late postmenopause.Eur J Obstet Gynecol Reprod Biol 2009;145:81-84.
62. Tom SE, Kuh D, Guralnik JM, Mishra GD. Self-reported sleep difficultyduring the menopausal transition: results from a prospective cohort study.Menopause 2010;17:1128-1135.
63. Beck AT, Steer RA, Carbin MG. Psychometric properties of the BeckDepression Inventory: twenty-five years of evaluation. Clin Psychol Rev1988;8:77-100.
64. Spielberger CD. State-Trait Anxiety Inventory: Bibliography, 2nd ed.Palo Alto, CA: Consulting Psychologists Press, 1989.